Mean days alive, out of hospital did not differ with vs without discontinuation.

Results from a randomised controlled HOME BP trial.

Meta-analysis results suggest need for special attention to high-risk younger patients.

Analysis show these medications not affect COVID-19 susceptibility risk

New therapies, revised regimens, trends, and of course COVID-19 are all on the list.

Shutdowns compromised quality of care, and new strategies are needed.

It is unclear if the findings extend to COVID-19.

They also develop HF more frequently.

Calcium channel blockers might outperform ACEIs/ARBs over age 75 years.

There was a strong association between diastolic blood pressure before the age of 50 years and brain damage in later life.

Benefit seen in patients with overweight or obesity and hypertension or T2D.

Renin inhibitors might have a slight edge in BP reductions, but bias is suspected.

Variable technique, values hold potential for overtreatment to hit SPRINT targets.

A nested case-control study about different suicide risk and exposure to angiotensin receptor blockers or angiotensin-converting enzyme inhibitors.